Members of our team had the opportunity to present a new poster abstract, "Improving Asthma Care Through Patient-Reported Outcome Measure Optimization", at the NASP 2025 Annual Meeting & Expo.

Authors:

Casey Fitzpatrick, PharmD; Andrew Wash, PharmD, PhD; Ana I. Lopez-Medina, PharmD, PhD; Lauren Bryant, PharmD, CDCES; Nicholas McDonald, PharmD; Jessica Mourani, PharmD

Background:

• Optimizing asthma control is paramount in ensuring patients with asthma live a normal life but is 

  often overestimated in clinical practice.¹

• To assess asthma control, guidelines recommend evaluating current asthma symptoms and the risk of future exacerbations.²

• The Asthma Impairment and Risk Questionnaire (AIRQ) is a validated patient-reported outcome measure (PROM) of asthma control that encompasses both domains.³

• Health-system specialty pharmacies (HSSPs) often rely on PROMs, such as the AIRQ, to monitor the 

  effectiveness and safety of medications. Selecting PROMs that optimize patient outcomes while 

  maintaining operational efficiency and data quality is essential in these settings.

Objectives:

• To describe the integration of a new PROM aimed at optimizing care for patients with asthma into an existing HSSP clinical management process.
  

Read about the team's findings by downloading the outcomes study below.

¹ Panettieri RA Jr, Chipps BE, Moore WC, et al. Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United States. J Asthma. 2022;59(9):1859-1868. doi:10.1080/02770903.2021.1963766

² Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2024. Available from:  www.ginasthma.org. Updated May 2024. Accessed June 25, 2025.

³ Chipps B, Zeiger RS, Beuther DA, et al. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control. Ann Allergy Asthma lmmunol. 2023;131(4):436- 443.el. doi:10.1016/j.anai.2023.04.024